Journal
BRITISH JOURNAL OF CANCER
Volume 89, Issue 3, Pages 513-518Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bjc.6601042
Keywords
contralateral breast cancer; body mass index; c-erbB-2
Categories
Funding
- NCI NIH HHS [N01-CN-0532, 1 R01 CA-71735, R01 CA059736, R01 CA-41416, 2 R01 CA-59736, R01 CA041416, 1R01 CA-59736] Funding Source: Medline
Ask authors/readers for more resources
Women diagnosed with a first breast cancer before the age of 45 years have a greater than 5.0-fold risk of developing a second primary contralateral breast cancer (CBC) than women in the general population have of developing a first breast cancer. Identifying epidemiologic or molecular factors that influence CBC risk could aid in the development of new strategies for the management of these patients. A total of 1285 participants in two case-control studies conducted in Seattle, Washington, who were 21-44 years of age when diagnosed with a first invasive breast carcinoma from 1983 to 1992, were followed through December 2001. Of them, 77 were diagnosed with CBC and 907 tumour tissues from first cancers were analysed. Women with body mass indices (BMIs) greater than or equal to 30 kg m(-2) had a 2.6-fold greater risk (95% CI: 1.1-5.9) of CBC compared to women with BMIs less than or equal to 19.9 kg m(-2). Women whose first tumour was c-erbB-2 positive had a 1.7-fold (95% CI: 1.0-3.0) excess CBC risk. Body mass index and c-erbB-2 expression may be risk factors for CBC in young women. Further observational studies are needed to confirm these findings and to evaluate whether testing for c-erbB-2 in this population may help identify those at high risk for CBC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available